Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum.

Jongmin Lee Hyemin Jang Sung Hoon Kang Jae Ho Kim Ji-Sun Kim Jun Pyo Kim Hee Jin Kim Sang Won Seo Duk Lyul Na

Published in: Journal of Korean medical science (2020)

CSF biomarkers had high sensitivity and specificity in differentiating ADD from NC and were as accurate as amyloid PET. The ATN subtypes based on CSF biomarkers may further serve to predict the prognosis.

Keyphrases

cerebrospinal fluid
machine learning
computed tomography
deep learning
magnetic resonance imaging
cognitive decline
positron emission tomography
pet ct
high resolution
magnetic resonance
mass spectrometry
pet imaging
contrast enhanced